Parabilis Medicines

📍 Cambridge, United States🗓 Founded 2016👥 195 employees💰 Last funded Jun 2026
Biotechnology Research🌐 parabilismed.com
Website LinkedIn
Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact.
4
Total investors
3
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Hong Kong SAR
1
Investor activity2017–2026 · investors recorded per year
201712018220261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Parabilis Medicines?
Parabilis Medicines has 4 investors on record on gritt.io, including 3 early-stage backers and 1 late-stage investors.
When did Parabilis Medicines last raise funding?
The most recent investment in Parabilis Medicines recorded on gritt.io was in June 2026.
When was Parabilis Medicines founded?
Parabilis Medicines was founded in 2016.
What industry is Parabilis Medicines in?
Parabilis Medicines operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Parabilis Medicines based?
Parabilis Medicines is headquartered in Cambridge, United States.